Erik A. Ehli received his BS in Biology from Northern State University, and MS in Basic Biological Sciences from University of South Dakota. He currently works as a Research Scientist at Avera Genetics. He is leading genotyping projects on samples collected from children and adolescents through the Netherlands Twin Register. His works mainly focus on the molecular characterization of metastatic breast cancer as well as understanding the tumor genetics of gynecological cancer, specifically uterine sarcoma. He has experienced in extensive training in a diverse range of molecular genetics techniques, including high density SNP genotyping, methylation, next generation sequencing, and pharmacogenetic profiling. His research interest includes the molecular genetics of complex diseases.
Erik A. Ehli received his BS in Biology from Northern State University, and MS in Basic Biological Sciences from University of South Dakota. He currently works as a Research Scientist at Avera Genetics. He is leading genotyping projects on samples collected from children and adolescents through the Netherlands Twin Register. His works mainly focus on the molecular characterization of metastatic breast cancer as well as understanding the tumor genetics of gynecological cancer, specifically uterine sarcoma. He has experienced in extensive training in a diverse range of molecular genetics techniques, including high density SNP genotyping, methylation, next generation sequencing, and pharmacogenetic profiling. His research interest includes the molecular genetics of complex diseases.